OraSure Technologies Reports OMNIgene®·ORAL Device Now Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
The company advises this EUA amendment will allow 3B BlackBio Biotech’s North American distributor, Genophyll Enterprises, to expand saliva COVID-19 PCR-based viral diagnostic testing across the U.S. as well as from their upcoming New Jersey-based laboratory.